Pregnancy induced hypertension (PIH) is a condition which complicates 1 in every 10 pregnant women. PIH is one of the main risk factor for increasing cardio vascular disease in women and other complications. PIH is also responsible for both maternal and foetal morbidity and mortality rate. So it was necessary to assess the prevalence, to identify the risk factors and to assess the prescription pattern of PIH, whereby the further complications in pregnant women and foetus can be prevented to a larger extend. The objectives of the present study were to assess the prevalence of pregnancy induced hypertension, identification of the risk factors and prescription pattern of pregnancy induced hypertension. This was a prospective observational study which was carried out for a period of six months at OBG department of Basaveshwara Medical College Hospital and Research Centre, Chitradurga, Karnataka. The prevalence of pregnancy induced hypertension was found to be 21%. The risk factors identified for PIH in this particular study was pregnant women with age>30, pregnant women who were obese, pregnant women with a family history of PIH and previous pregnancy induced PIH, pregnant women who didn’t have a regular antenatal care checkups had PIH. The most commonly prescribed drug was calcium channel blockers (i.e., amlodipine and nifedipine), followed by diuretics (i.e., furosemide and spironolactone combination and mannitol), mixed alpha and beta blockers (i.e., labetalol), centrally acting sympatholytics (i.e., methyl dopa) and beta blockers (i.e., atenolol). The prevalence of PIH was comparatively more in this study. The risk factors identified in this study were found to have a significant association with PIH. The most commonly prescribed drugs had a positive impact on the study subjects.
Loading....